Northside Hospital Cancer Institute Immunotherapy Program is one of just two programs in Georgia to offer the latest chimeric antigen receptor (CAR) T-cell immunotherapy. TECARTUS™ (brexucabtagene autoleucel), from Kite Pharma, Inc.,…
Read MoreThis was created and published by the Northside Hospital Foundation CLICK THE PICTURE TO READ THEIR STORIES
Read MoreThis was created and published by the Northside Hospital Foundation CLICK THE PICTURE TO READ THEIR STORIES
Read MoreThis was created and published by the Northside Hospital Foundation CLICK THE PICTURE TO READ THEIR STORIES
Read More